Diseases, Conditions, Syndromes

How omicron escapes from antibodies

A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.

Genetics

New resource to advance genomics-driven precision medicine

By analyzing genomic data from more than 30,000 people, an international team has revealed thousands of new regulatory regions that control disease-linked genes—a resource that is now available to researchers worldwide.

Medical economics

Researchers find gaps in clinical trial data sharing

Access to clinical-trial data helps doctors make informed prescribing decisions and promotes good science, but a new study co-authored by Yale researchers reveals that few pharmaceutical companies are fully transparent about ...

page 5 from 40